# Bausch Health Companies Inc. (BHC) FY2026 Q2 Balance Sheet

- Company: Bausch Health Companies Inc. (BHC)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-30, accession number 0000885590-26-000107
- Page: https://plicit.ai/financials/bhc/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/bhc-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 24,794,000,000 US dollars
- **Current assets**: 6,522,000,000 US dollars
- **Non-current assets**: 18,272,000,000 US dollars
- **Liabilities**: 25,596,000,000 US dollars
- **Current liabilities**: 4,544,000,000 US dollars
- **Non-current liabilities**: 21,052,000,000 US dollars
- **Equity**: negative 802,000,000 US dollars
- **Noncontrolling interest**: 969,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Trade receivables, net**: 2,263,000,000 US dollars
- **Cash and cash equivalents**: 1,825,000,000 US dollars
- **Inventories, net**: 1,602,000,000 US dollars
- **Prepaid expenses and other current assets**: 819,000,000 US dollars
- **Restricted cash**: 13,000,000 US dollars
- **Goodwill**: 9,793,000,000 US dollars
- **Intangible assets, net**: 4,179,000,000 US dollars
- **Property, plant and equipment, net**: 2,097,000,000 US dollars
- **Deferred tax assets, net**: 1,845,000,000 US dollars
- **Other non-current assets**: 358,000,000 US dollars
- **Accrued and other current liabilities**: 3,070,000,000 US dollars
- **Current portion of long-term debt**: 866,000,000 US dollars
- **Accounts payable**: 593,000,000 US dollars
- **Financial leases**: 15,000,000 US dollars
- **Non-current portion of long-term debt**: 19,875,000,000 US dollars
- **Other non-current liabilities**: 733,000,000 US dollars
- **Deferred tax liabilities, net**: 211,000,000 US dollars
- **Acquisition-related contingent consideration**: 210,000,000 US dollars
- **Non-current portion of financial leases**: 23,000,000 US dollars
- **Common shares, no par value, unlimited shares authorized, 373,901,440 and 370,531,987 issued and outstanding at June 30, 2026 and December 31, 2025, respectively**: 10,544,000,000 US dollars
- **Additional paid-in capital**: 342,000,000 US dollars
- **Noncontrolling interest**: 969,000,000 US dollars
- **Accumulated deficit**: negative 10,832,000,000 US dollars
- **Accumulated other comprehensive loss**: negative 1,825,000,000 US dollars

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.